Benzinga·Feb 26·Lekha GuptaSynopsys Shares Slide on Weak Guidance Despite Earnings BeatSynopsys beat Q1 earnings but stock fell 3.44% on weak forward guidance, flat IP revenue, and China weakness concerns. SNPSstock declineSynopsys
Benzinga·Feb 26·Lekha GuptaCrowdStrike Slips Despite VAST Data AI Security PartnershipCrowdStrike shares fell 0.79% despite announcing an AI security partnership with VAST Data. Stock remains significantly below recent averages amid broader technical weakness. CRWDstock declinetechnical analysis
Investing.com·Feb 26·Zacks Investment ResearchMicroStrategy Stock Down 60% Despite Substantial Bitcoin HoldingsMicroStrategy stock down 60% despite holding 717,131 Bitcoin. Market concerns over leverage and dilution overshadow strong treasury position and recent $25.3B capital raise. RIOTHUTHIVEstock declinetechnical analysis
GlobeNewswire Inc.·Feb 26·ClaimsfilerNavan Class Action Deadline Approaches for IPO Investors With Substantial LossesNavan IPO investors with losses over $100,000 have until April 24, 2026 to file for lead plaintiff status in a class action alleging the company concealed marketing expense increases before going public. NAVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Feb 25·Bragar Eagel & Squire, P.C.Law Firm Launches Investigation Into Alight Following Disappointing Earnings and Stock DeclineLaw firm investigates Alight after company reported $800M goodwill impairment, missed earnings expectations, and triggered 35% stock decline. ALITstock declinefinancial results
GlobeNewswire Inc.·Feb 25·Kirby Mcinerney LlpPayPal Hit With Securities Fraud Suit Over Alleged Misstatements on Growth TargetsPayPal faces securities fraud lawsuit for allegedly misleading investors about growth targets and revenue outlook. Stock fell 20% after disappointing earnings and CEO departure. PYPLsecurities fraudclass action lawsuit
Benzinga·Feb 25·Business WireDriven Brands Restatement Triggers 40% Stock Plunge, Securities Probe LaunchedDriven Brands stock plummets 40% after restating financials due to multi-year accounting errors including improper revenue recognition and lease accounting. Securities fraud probe launched. DRVNsecurities fraudstock decline
GlobeNewswire Inc.·Feb 25·Faruqi & Faruqi, LlpDriven Brands Faces Investor Investigation After Restatement of Financial StatementsDriven Brands faces investor investigation after restating financial statements due to material accounting errors in lease accounting, cash irregularities, and overstated expenses. Stock fell 30%. DRVNstock declineinternal control weaknesses
Benzinga·Feb 25·Business WireLaw Firm Launches Securities Probe Into Tennant After Earnings MissLaw firm investigates Tennant Company for potential securities violations after massive earnings miss attributed to ERP system implementation problems. Stock fell 23.4%. TNCstock declineearnings miss
Benzinga·Feb 25·Erica KollmannTrade Desk Shares Tumble on Weak Forward Guidance Despite Q4 Earnings BeatTrade Desk beat Q4 earnings expectations but shares tumbled 14.67% after providing weak forward guidance, signaling management caution on near-term advertising demand. TTDstock declineearnings
The Motley Fool·Feb 25·Steven PorrelloUSA Rare Earth Stock Falls 41% From Peak as Production Timeline ExtendsUSA Rare Earth stock plunged 41% from October peak as production timelines extend, with magnet factory opening delayed to mid-2026 and mining production pushed to 2028. USARstock declinesupply chain
GlobeNewswire Inc.·Feb 25·Hagens BermanFermi Inc. Faces Securities Lawsuit Over Project Matador DisclosuresFermi Inc. faces securities lawsuit alleging misleading statements about Project Matador AI data center. Stock fell 59% after primary tenant terminated $150M funding agreement. FRMIstock declinesecurities class action
The Motley Fool·Feb 25·Daniel SparksAmerican Express Shares Drop 12% Despite Strong Earnings and Growth OutlookAmerican Express stock dropped 12% despite strong 2025 earnings growth and positive 2026 guidance, suggesting market concerns about credit quality and macro risks. AXPstock declinevaluation
Benzinga·Feb 25·Evette MitkovInfleqtion Shares Fall Below IPO Price in Post-Merger TradingInfleqtion shares fell 7% below their IPO opening price after completing a SPAC merger, now trading at 52-week lows amid broader market weakness and typical post-merger price discovery. INFQINFQ.WSstock declineSPAC merger
Benzinga·Feb 25·Lekha GuptaSteven Madden Beats Earnings Despite Tariff Uncertainty, Withholds 2026 OutlookSteven Madden beat Q4 earnings estimates with strong DTC growth, but withheld 2026 guidance citing tariff uncertainty and acquisition costs, causing shares to decline 6.56%. SHOOstock declineearnings
GlobeNewswire Inc.·Feb 25·Holzer & Holzer, LlcSecurities Investigation Launched Into ODDITY Tech Following Ad Partner DisruptionSecurities firm investigating ODDITY Tech after algorithmic glitch disrupted major ad partner, causing stock decline. Probe examines if company disclosed material information timely and adequately. ODDstock declinefinancial results
The Motley Fool·Feb 25·Keith NoonanDuolingo Shares Lose Over One-Third of Value Amid Growth Strategy ShiftDuolingo stock plummeted 38% year-to-date after weak Q4 guidance and the company's shift to prioritize user growth over revenue, sparking investor concerns about near-term performance. DUOLstock declineearnings guidance
The Motley Fool·Feb 25·James BrumleyCarvana Stock Tumbles 10% Post-Earnings as Profitability Concerns PersistCarvana stock dropped 10% post-earnings as profitability concerns persist despite 58% revenue growth. Compressed margins and missed EBITDA expectations weigh on investor sentiment. CVNAstock declinerevenue growth
GlobeNewswire Inc.·Feb 25·Kahn Swick & Foti, LlcuniQure Faces Securities Fraud Lawsuit Following FDA Rejection, 49% Stock PlungeuniQure faces securities fraud lawsuit after FDA rejected its drug candidate AMT-130, causing a 49% stock plunge. Plaintiffs allege the company failed to disclose material information to investors. CORTBRBRQUREsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Feb 25·Kahn Swick & Foti, LlcCorcept Therapeutics Faces Securities Fraud Lawsuit Over Undisclosed FDA SetbackCorcept Therapeutics faces securities fraud lawsuit for failing to disclose FDA setback on relacorilant drug, causing 50% stock decline. CORTBRBRQUREsecurities fraudclass action lawsuit